Augmented Renal Clearance and How to Augment Antibiotic Dosing

被引:60
|
作者
Chen, Iris H. [1 ]
Nicolau, David P. [1 ]
机构
[1] Hartford Hosp, Ctr Antiinfect Res & Dev, 80 Seymour St, Hartford, CT 06102 USA
来源
ANTIBIOTICS-BASEL | 2020年 / 9卷 / 07期
关键词
augmented renal clearance; antibiotic; critical care; subtherapeutic; pharmacokinetics; pharmacodynamics; CRITICALLY-ILL; CREATININE CLEARANCE; CLINICAL-OUTCOMES; COCKCROFT-GAULT; NOSOCOMIAL PNEUMONIA; RISK-FACTORS; VANCOMYCIN; THERAPY; THROMBOCYTOPENIA; PIPERACILLIN;
D O I
10.3390/antibiotics9070393
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Augmented renal clearance (ARC) refers to the state of heightened renal filtration commonly observed in the critically ill. Its prevalence in this patient population is a consequence of the body's natural response to serious disease, as well as the administration of fluids and pharmacologic therapies necessary to maintain sufficient blood pressure. ARC is objectively defined as a creatinine clearance of more than 130 mL/min/1.73 m(2)and is thus a crucial condition to consider when administering antibiotics, many of which are cleared renally. Using conventional dosing regimens risks the possibility of subtherapeutic concentrations or clinical failure. Over the past decade, research has been conducted in patients with ARC who received a number of antibacterials frequently used in the critically ill, such as piperacillin-tazobactam or vancomycin. Strategies to contend with this condition have also been explored, though further investigations remain necessary.
引用
收藏
页码:1 / 12
页数:12
相关论文
共 50 条
  • [21] Pharmacists' Knowledge About the Impact of Augmented Renal Clearance on Antimicrobial Dosing in Critically Ill Patients: A Cross-Sectional Study
    Almulhim, Abdulaziz S.
    Al-Dahneen, Batool A.
    Alsowaida, Yazed S.
    INFECTIOUS DISEASES AND THERAPY, 2020, 9 (03) : 599 - 608
  • [22] Optimizing Aminoglycoside Dosing Regimens for Critically III Pediatric Patients with Augmented Renal Clearance: a Convergence of Parametric and Nonparametric Population Approaches
    Avedissian, Sean N.
    Rohani, Roxane
    Bradley, John
    Le, Jennifer
    Rhodes, Nathaniel J.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2021, 65 (04)
  • [23] The Impact of Augmented Renal Clearance on Vancomycin Pharmacokinetics and Pharmacodynamics in Critically Ill Patients
    Tesfamariam, Novel Solomon
    Aboelezz, Asma
    Mahmoud, Sherif Hanafy
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (08)
  • [24] Onset timing and duration of augmented renal clearance in a mixed intensive care unit
    Mikami, Ryusei
    Hayakawa, Mineji
    Imai, Shungo
    Sugawara, Mitsuru
    Takekuma, Yoh
    JOURNAL OF INTENSIVE CARE, 2023, 11 (01)
  • [25] Augmented Renal Clearance in Pediatric Patients With Febrile Neutropenia Associated With Vancomycin Clearance
    Hirai, Keita
    Ihara, Setsuko
    Kinae, Ayumi
    Ikegaya, Kenichi
    Suzuki, Masayuki
    Hirano, Keiko
    Itoh, Kunihiko
    THERAPEUTIC DRUG MONITORING, 2016, 38 (03) : 393 - 397
  • [26] Augmented Renal Clearance Implications for Antibacterial Dosing in the Critically Ill
    Udy, Andrew A.
    Roberts, Jason A.
    Boots, Robert J.
    Paterson, David L.
    Lipman, Jeffrey
    CLINICAL PHARMACOKINETICS, 2010, 49 (01) : 1 - 16
  • [27] Development and External Validation of an Online Clinical Prediction Model for Augmented Renal Clearance in Adult Mixed Critically Ill Patients: The Augmented Renal Clearance Predictor
    Gijsen, Matthias
    Huang, Chao-Yuan
    Flechet, Marine
    Van Daele, Ruth
    Declercq, Peter
    Debaveye, Yves
    Meersseman, Philippe
    Meyfroidt, Geert
    Wauters, Joost
    Spriet, Isabel
    CRITICAL CARE MEDICINE, 2020, 48 (12) : E1260 - E1268
  • [28] β-Lactam Dosage Regimens in Septic Patients with Augmented Renal Clearance
    Jacobs, Alexandra
    Taccone, Fabio Silvio
    Roberts, Jason A.
    Jacobs, Frederique
    Cotton, Frederic
    Wolff, Fleur
    Creteur, Jacques
    Vincent, Jean-Louis
    Hites, Maya
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2018, 62 (09)
  • [29] Population Pharmacokinetics and Dosing Optimization of Vancomycin in Infants, Children, and Adolescents with Augmented Renal Clearance
    He, Cui-Yao
    Ye, Pan-Pan
    Liu, Bin
    Song, Lin
    van den Anker, John
    Zhao, Wei
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2021, 65 (10)
  • [30] Vancomycin population pharmacokinetics and dosing recommendations in haematologic malignancy with augmented renal clearance children
    Lv, Chun-Le
    Lu, Jie-Jiu
    Chen, Ming
    Zhang, Ren
    Li, Qiao-Chuan
    Chen, Yi-Yu
    Liu, Tao-Tao
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2020, 45 (06) : 1278 - 1287